2022-08-25 | CSE:PHRX | Press Release | Pharmadrug Inc.

(2022-08-25 | CSE:PHRX) PharmaDrug Advances Psychedelics Pharmaceutical Program Focused on DMT and DMT Analogues

Related Keywords

United States ,Canada ,Toronto ,Ontario ,Michigan ,Canadian ,Jimo Borjigin ,Fredericks Barrett ,Daniel Cohen ,Sandeep Nayak ,Roland Griffiths ,Johns Hopkins University ,Clinical Research Collaboration ,Pharmadrug Inc ,Drug Administration ,Collaborative Research Agreement ,Johns Hopkins University To Evaluate ,University Of Michigan ,Terasaki Institute For Biomedical Innovation ,Newsfile Corp ,Consciousness Research ,Behavioral Sciences ,Terasaki Institute ,Biomedical Innovation ,Research Agreement ,Terasaki Institute Leads ,Potential New Treatment ,United States Food ,Research Collaboration ,Associate Professor ,Drug Supports Foundational Research Aimed ,Understanding Role ,Sairiyo Therapeutics ,Super Smart ,Regarding Forward Looking Information ,Healthcare 37 ,Drug Manufacturers Major 122 ,Medical Care 126 ,Cannabis 69303 ,Can 7 ,Usa 8 ,Drug Manufacturers Major 130070 ,